NASDAQ · Healthcare · Biotechnology
BlossomHill Therapeutics, Inc.
BLSM
Blossomhill Therapeutics, Inc. CEO Jing Rong Jean Cui · Market cap $497.3M.
$17.10
+0.49 · +2.95%
52w hi $27.9952w lo $15.25
Off 52w high 5.9%
69
NOTABLE
Current InsiderScore
Corp · 90d
6
6 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
4
0 strong · 4 notable
Analyst consensus
—
—
Section 01
Recent Form 4 filings
6 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Aug 10 | John P. Schmid | Buy | 6,000 | $16.00 | +$96K | 65 | |
| Aug 10 | Vincent Paul Liptak | General Counsel | Buy | 2,200 | $16.00 | +$35K | 52 |
| Aug 10 | Bihua Chen | Buy | 312,500 | $16.00 | +$5.00M | 68 | |
| Aug 10 | Carl L Gordon | Buy | 625,000 | $16.00 | +$10.00M | 69 | |
| Aug 10 | ORBIMED ADVISORS LLC | Buy | 625,000 | $16.00 | +$10.00M | 69 | |
| Aug 07 | Vincent Paul Liptak | General Counsel | Buy | 2,500 | $15.80 | +$40K | 52 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
NovDecJanFebMarAprMayJunJulAugSepOct